{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:59:20Z","timestamp":1788922760677,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009076","name":"University of Science and Technology of China","doi-asserted-by":"publisher","award":["2024-RE-214"],"award-info":[{"award-number":["2024-RE-214"]}],"id":[{"id":"10.13039\/501100009076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010814","name":"Anhui Province Department of Education","doi-asserted-by":"publisher","award":["2022AH020077"],"award-info":[{"award-number":["2022AH020077"]}],"id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.transproceed.2025.02.041","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T04:36:58Z","timestamp":1741927018000},"page":"580-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Successful Liver Transplantation After Achieving Complete Clinical Remission of Hepatocellular Carcinoma With Combination Therapy of Immune Checkpoint Inhibitors and Targeted Agents: A Case Report"],"prefix":"10.1016","volume":"57","author":[{"given":"Shaobo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shugeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.transproceed.2025.02.041_bib0001","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41571-024-00868-0","article-title":"Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma","volume":"21","author":"Llovet","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"10.1016\/j.transproceed.2025.02.041_bib0002","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.3390\/curroncol29120771","article-title":"Rangnekar AS. immunotherapy use prior to liver transplant in patients with hepatocellular carcinoma","volume":"29","author":"Woo","year":"2022","journal-title":"Curr Oncol"},{"issue":"12","key":"10.1016\/j.transproceed.2025.02.041_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123202","article-title":"Pathogenesis and current treatment strategies of hepatocellular carcinoma","volume":"10","author":"T\u00fcmen","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.transproceed.2025.02.041_bib0004","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.3389\/ti.2023.11648","article-title":"European society of organ transplantation (ESOT) consensus report on downstaging, bridging and immunotherapy in liver transplantation for hepatocellular carcinoma","volume":"36","author":"Claasen","year":"2023","journal-title":"Transpl Int."},{"issue":"7","key":"10.1016\/j.transproceed.2025.02.041_bib0005","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ueg2.12286","article-title":"New concepts in the treatment of hepatocellular carcinoma","volume":"10","author":"Sidali","year":"2022","journal-title":"United European Gastroenterol J"},{"issue":"6","key":"10.1016\/j.transproceed.2025.02.041_bib0006","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jhep.2023.01.030","article-title":"Liver transplantation immunology: immunosuppression, rejection, and immunomodulation","volume":"78","author":"Montano-Loza","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.transproceed.2025.02.041_bib0007","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4251\/wjgo.v14.i1.163","article-title":"Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons","volume":"14","author":"Luo","year":"2022","journal-title":"World J Gastrointest Oncol"},{"issue":"11","key":"10.1016\/j.transproceed.2025.02.041_bib0008","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5500\/wjt.v12.i11.331","article-title":"Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation","volume":"12","author":"Ouranos","year":"2022","journal-title":"World J Transplant"},{"issue":"4","key":"10.1016\/j.transproceed.2025.02.041_bib0009","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/hep.31234","article-title":"Immunotherapy as a downstaging therapy for liver transplantation","volume":"72","author":"Schwacha-Eipper","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2025.02.041_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1205997","article-title":"Case Report: Successful liver transplantation after achieving complete clinical remission of advanced HCC with atezolizumab plus bevacizumab combination therapy","volume":"14","author":"Chouik","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.transproceed.2025.02.041_bib0011","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.radcr.2023.11.062","article-title":"Abscopal downstaging of intermediate stage hepatocellular via combination cryoablation and immunotherapy with complete pathologic response","volume":"19","author":"Lucas","year":"2024","journal-title":"Radiol Case Rep"},{"issue":"3","key":"10.1016\/j.transproceed.2025.02.041_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032358","article-title":"Immunotherapy for hepatocellular carcinoma in the setting of liver transplantation: a review","volume":"24","author":"Lominadze","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"21","key":"10.1016\/j.transproceed.2025.02.041_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15215115","article-title":"Hepatocellular Carcinoma: The role of immunotherapy and transplantation in the era of transplant oncology","volume":"15","author":"Alghamdi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.transproceed.2025.02.041_bib0014","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/ajt.15617","article-title":"Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: are checkpoint inhibitors safe for the pretransplant patient?","volume":"20","author":"Nordness","year":"2020","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.transproceed.2025.02.041_bib0015","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/ajt.16448","article-title":"PD-1 inhibitor as bridge therapy to liver transplantation?","volume":"21","author":"Tabrizian","year":"2021","journal-title":"Am J Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113452500137X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113452500137X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T01:12:36Z","timestamp":1744506756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113452500137X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S004113452500137X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2025.02.041","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful Liver Transplantation After Achieving Complete Clinical Remission of Hepatocellular Carcinoma With Combination Therapy of Immune Checkpoint Inhibitors and Targeted Agents: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2025.02.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}